Sugammadex Titration in Cardiac Surgery Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

November 10, 2022

Study Completion Date

November 10, 2022

Conditions
Coronary Artery DiseaseValvular Heart DiseaseAorta DiseaseHeart Failure
Interventions
DRUG

Sugammadex administration

Sugammadex will be given in 50 mg increments every five minutes for reversal of neuromuscular blockade until reaching a train-of-four ratio of 0.9

Trial Locations (1)

98195

University of Washington Medical Center, Seattle

All Listed Sponsors
lead

University of Washington

OTHER